M1 Kliniken Past Earnings Performance
Past criteria checks 4/6
M1 Kliniken's earnings have been declining at an average annual rate of -0.9%, while the Healthcare industry saw earnings declining at 0.6% annually. Revenues have been growing at an average rate of 30.8% per year. M1 Kliniken's return on equity is 8.1%, and it has net margins of 3.2%.
Key information
-0.9%
Earnings growth rate
-3.5%
EPS growth rate
Healthcare Industry Growth | 15.7% |
Revenue growth rate | 30.8% |
Return on equity | 8.1% |
Net Margin | 3.2% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Why We're Not Concerned Yet About M1 Kliniken AG's (ETR:M12) 27% Share Price Plunge
Aug 03Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings
Jun 06M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump
May 29M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively
May 03At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?
Mar 07Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge
Feb 18Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?
Feb 17An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued
Sep 01Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?
Jun 01The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence
Mar 25Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital
Dec 17Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?
Nov 02Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook
May 26Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results
May 25Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital
Dec 06There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital
May 22Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like
Mar 19We're Watching These Trends At M1 Kliniken (ETR:M12)
Feb 21M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment
Feb 03Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?
Jan 16M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Dec 29Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 14When Should You Buy M1 Kliniken AG (ETR:M12)?
Nov 28Revenue & Expenses Breakdown
How M1 Kliniken makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 316 | 10 | 2 | 0 |
30 Sep 23 | 307 | 8 | 2 | 0 |
30 Jun 23 | 297 | 6 | 2 | 0 |
31 Mar 23 | 291 | 5 | 2 | 0 |
31 Dec 22 | 285 | 4 | 2 | 0 |
30 Sep 22 | 287 | 6 | 2 | 0 |
30 Jun 22 | 288 | 7 | 2 | 0 |
31 Mar 22 | 302 | 8 | 2 | 0 |
31 Dec 21 | 315 | 9 | 2 | 0 |
30 Sep 21 | 304 | 9 | 2 | 0 |
30 Jun 21 | 293 | 10 | 2 | 0 |
31 Mar 21 | 226 | 8 | 2 | 0 |
31 Dec 20 | 160 | 7 | 2 | 0 |
30 Sep 20 | 118 | 7 | 2 | 0 |
30 Jun 20 | 76 | 6 | 1 | 0 |
31 Mar 20 | 77 | 8 | 1 | 0 |
31 Dec 19 | 77 | 10 | 1 | 0 |
30 Sep 19 | 73 | 8 | 2 | 0 |
30 Jun 19 | 69 | 7 | 2 | 0 |
31 Mar 19 | 67 | 7 | 2 | 0 |
31 Dec 18 | 65 | 7 | 2 | 0 |
30 Sep 18 | 60 | 6 | 2 | 0 |
30 Jun 18 | 54 | 5 | 2 | 0 |
31 Mar 18 | 51 | 6 | 2 | 0 |
31 Dec 17 | 47 | 6 | 2 | 0 |
30 Sep 17 | 43 | 6 | 1 | 0 |
30 Jun 17 | 40 | 6 | 0 | 0 |
31 Mar 17 | 38 | 5 | 0 | 0 |
31 Dec 16 | 36 | 5 | 0 | 0 |
30 Sep 16 | 40 | 7 | 0 | 0 |
30 Jun 16 | 43 | 10 | 0 | 0 |
31 Mar 16 | 39 | 8 | 0 | 0 |
31 Dec 15 | 35 | 7 | 0 | 0 |
31 Dec 14 | 23 | 5 | 0 | 0 |
31 Dec 13 | 6 | 0 | 0 | 0 |
Quality Earnings: M12 has high quality earnings.
Growing Profit Margin: M12's current net profit margins (3.2%) are higher than last year (1.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: M12's earnings have declined by 0.9% per year over the past 5 years.
Accelerating Growth: M12's earnings growth over the past year (138%) exceeds its 5-year average (-0.9% per year).
Earnings vs Industry: M12 earnings growth over the past year (138%) exceeded the Healthcare industry 30.9%.
Return on Equity
High ROE: M12's Return on Equity (8.1%) is considered low.